Site Development Lead
In 2019 AstraZeneca began to explore how to make smarter site selection decisions by leveraging electronic health record systems capability to pre-identify potential participant clusters. They discovered that the success of this strategy is rooted in three primary drivers: technology platform capabilities, data access across multiple institutional platforms and institutional line-of site across the patient care delivery system. The findings suggest that although the technology capabilities are important the drivers are the human factors: leadership support of cross institutional database access and institutional line of site into patient care access points. Successful implementation of an EMR strategy is achievable but awareness of an individual site’s commitment to this process is essential to converting the numeral data to patient lives impacted by clinical research.
